Parker Institute for Cancer Immunotherapy (PICI) shared a post on LinkedIn:
“Join PICI in Washington, DC, on Wednesday, May 6th, for “Unlocking Next-Generation Therapies,” hosted in partnership with Friends of Cancer Research. This public meeting will bring together leaders across academia, industry, regulatory, and patient advocacy to explore how to advance next-generation, cell-based therapies and accelerate their development.
The day will focus on modernizing first-in-human clinical trials, operationalizing risk-based CMC flexibility, and exploring pathways to maintain global competitiveness without compromising patient safety or product quality.
Other articles featuring PICI on OncoDaily.